{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:48:21Z","timestamp":1776919701636,"version":"3.51.2"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1093\/carcin\/bgi373","type":"journal-article","created":{"date-parts":[[2006,3,3]],"date-time":"2006-03-03T01:24:17Z","timestamp":1141349057000},"page":"1316-1322","source":"Crossref","is-referenced-by-count":24,"title":["Epigenetic alterations in RASSF1A in human aberrant crypt foci"],"prefix":"10.1093","volume":"27","author":[{"given":"Emily J.","family":"Greenspan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Jablonski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiruchandurai V.","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn S.","family":"Belinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel W.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,3,2]]},"reference":[{"key":"key\n\t\t\t\t20171011213230_B1","doi-asserted-by":"crossref","unstructured":"Bird,R.P. ( 1987 ) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. , 37 , 147 \u2013151.","DOI":"10.1016\/0304-3835(87)90157-1"},{"key":"key\n\t\t\t\t20171011213230_B2","unstructured":"Pretlow,T.P., Barrow,B.J., Ashton,W.S., O'Riordan,M.A., Pretlow,T.G., Jurcisek,J.A. and Stellato,T.A. ( 1991 ) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res. , 51 , 1564 \u20131567."},{"key":"key\n\t\t\t\t20171011213230_B3","doi-asserted-by":"crossref","unstructured":"Nucci,M.R., Robinson,C.R., Longo,P., Campbell,P. and Hamilton,S.R. ( 1997 ) Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum. Pathol. , 28 , 1396 \u20131407.","DOI":"10.1016\/S0046-8177(97)90230-6"},{"key":"key\n\t\t\t\t20171011213230_B4","doi-asserted-by":"crossref","unstructured":"Takayama,T., Katsuki,S., Takahashi,Y., Ohi,M., Nojiri,S., Sakamaki,S., Kato,J., Kogawa,K., Miyake,H. and Niitsu,Y. ( 1998 ) Aberrant crypt foci of the colon as precursors of adenoma and cancer. N. Engl. J. Med. , 339 , 1277 \u20131284.","DOI":"10.1056\/NEJM199810293391803"},{"key":"key\n\t\t\t\t20171011213230_B5","unstructured":"Jen,J., Powell,S.M., Papadopoulos,N., Smith,K.J., Hamilton,S.R., Vogelstein,B. and Kinzler,K.W. ( 1994 ) Molecular determinants of dysplasia in colorectal lesions. Cancer Res. , 54 , 5523 \u20135526."},{"key":"key\n\t\t\t\t20171011213230_B6","unstructured":"Heinen,C.D., Shivapurkar,N., Tang,Z., Groden,J. and Alabaster,O. ( 1996 ) Microsatellite instability in aberrant crypt foci from human colons. Cancer Res. , 56 , 5339 \u20135341."},{"key":"key\n\t\t\t\t20171011213230_B7","doi-asserted-by":"crossref","unstructured":"Otori,K., Konishi,M., Sugiyama,K., Hasebe,T., Shimoda,T., Kikuchi-Yanoshita,R., Mukai,K., Fukushima,S., Miyaki,M. and Esumi,H. ( 1998 ) Infrequent somatic mutation of the adenomatous polyposis coli gene in aberrant crypt foci of human colon tissue. Cancer , 83 , 896 \u2013900.","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<896::AID-CNCR14>3.0.CO;2-Q"},{"key":"key\n\t\t\t\t20171011213230_B8","doi-asserted-by":"crossref","unstructured":"Takayama,T., Ohi,M., Hayashi,T. et al . ( 2001 ) Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology , 121 , 599 \u2013611.","DOI":"10.1053\/gast.2001.27203"},{"key":"key\n\t\t\t\t20171011213230_B9","doi-asserted-by":"crossref","unstructured":"Hurlstone,D.P., Karajeh,M., Sanders,D.S., Drew,S.K. and Cross,S.S. ( 2005 ) Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia. Am. J. Gastroenterol. , 100 , 1283 \u20131289.","DOI":"10.1111\/j.1572-0241.2005.40891.x"},{"key":"key\n\t\t\t\t20171011213230_B10","doi-asserted-by":"crossref","unstructured":"Di Gregorio,C., Losi,L., Fante,R., Modica,S., Ghidoni,M., Pedroni,M., Tamassia,M.G., Gafa,L., Ponz de Leon,M. and Roncucci,L. ( 1997 ) Histology of aberrant crypt foci in the human colon. Histopathology , 30 , 328 \u2013334.","DOI":"10.1046\/j.1365-2559.1997.d01-626.x"},{"key":"key\n\t\t\t\t20171011213230_B11","doi-asserted-by":"crossref","unstructured":"Baylin,S.B., Herman,J.G., Graff,J.R., Vertino,P.M. and Issa,J.P. ( 1998 ) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. , 72 , 141 \u2013196.","DOI":"10.1016\/S0065-230X(08)60702-2"},{"key":"key\n\t\t\t\t20171011213230_B12","doi-asserted-by":"crossref","unstructured":"Chan,A.O., Broaddus,R.R., Houlihan,P.S., Issa,J.P., Hamilton,S.R. and Rashid,A. ( 2002 ) CpG island methylation in aberrant crypt foci of the colorectum. Am. J. Pathol. , 160 , 1823 \u20131830.","DOI":"10.1016\/S0002-9440(10)61128-5"},{"key":"key\n\t\t\t\t20171011213230_B13","doi-asserted-by":"crossref","unstructured":"Park,S.J., Rashid,A., Lee,J.H., Kim,S.G., Hamilton,S.R. and Wu,T.T. ( 2003 ) Frequent CpG island methylation in serrated adenomas of the colorectum. Am. J. Pathol. , 162 , 815 \u2013822.","DOI":"10.1016\/S0002-9440(10)63878-3"},{"key":"key\n\t\t\t\t20171011213230_B14","doi-asserted-by":"crossref","unstructured":"Rashid,A., Shen,L., Morris,J.S., Issa,J.P. and Hamilton,S.R. ( 2001 ) CpG island methylation in colorectal adenomas. Am. J. Pathol. , 159 , 1129 \u20131135.","DOI":"10.1016\/S0002-9440(10)61789-0"},{"key":"key\n\t\t\t\t20171011213230_B15","doi-asserted-by":"crossref","unstructured":"Wynter,C.V., Walsh,M.D., Higuchi,T., Leggett,B.A., Young,J. and Jass,J.R. ( 2004 ) Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut , 53 , 573 \u2013580.","DOI":"10.1136\/gut.2003.030841"},{"key":"key\n\t\t\t\t20171011213230_B16","doi-asserted-by":"crossref","unstructured":"Toyota,M., Ahuja,N., Ohe-Toyota,M., Herman,J.G., Baylin,S.B. and Issa,J.P. ( 1999 ) CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA , 96 , 8681 \u20138686.","DOI":"10.1073\/pnas.96.15.8681"},{"key":"key\n\t\t\t\t20171011213230_B17","unstructured":"Braakhuis,B.J., Tabor,M.P., Kummer,J.A., Leemans,C.R. and Brakenhoff,R.H. ( 2003 ) A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. , 63 , 1727 \u20131730."},{"key":"key\n\t\t\t\t20171011213230_B18","doi-asserted-by":"crossref","unstructured":"Shen,L., Kondo,Y., Rosner,G.L. et al . ( 2005 ) MGMT promoter methylation and field defect in sporadic colorectal cancer. J. Natl Cancer Inst. , 97 , 1330 \u20131338.","DOI":"10.1093\/jnci\/dji275"},{"key":"key\n\t\t\t\t20171011213230_B19","doi-asserted-by":"crossref","unstructured":"Dammann,R., Li,C., Yoon,J.H., Chin,P.L., Bates,S. and Pfeifer,G.P. ( 2000 ) Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. , 25 , 315 \u2013319.","DOI":"10.1038\/77083"},{"key":"key\n\t\t\t\t20171011213230_B20","doi-asserted-by":"crossref","unstructured":"Pfeifer,G.P. and Dammann,R. ( 2005 ) Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry (Mosc) , 70 , 576 \u2013583.","DOI":"10.1007\/s10541-005-0151-y"},{"key":"key\n\t\t\t\t20171011213230_B21","doi-asserted-by":"crossref","unstructured":"Tommasi,S., Dammann,R., Zhang,Z., Wang,Y., Liu,L., Tsark,W.M., Wilczynski,S.P., Li,J., You,M. and Pfeifer,G.P. ( 2005 ) Tumor susceptibility of RASSF1A knockout mice. Cancer Res. , 65 , 92 \u201398.","DOI":"10.1158\/0008-5472.92.65.1"},{"key":"key\n\t\t\t\t20171011213230_B22","doi-asserted-by":"crossref","unstructured":"Oliveira,C., Velho,S., Domingo,E., Preto,A., Hofstra,R.M., Hamelin,R., Yamamoto,H., Seruca,R. and Schwartz,S. ( 2005 ) Concomitant RASSF1A hypermethylation and KRAS\/BRAF mutations occur preferentially in MSI sporadic colorectal cancer. Oncogene , 24 , 7630 \u20137634.","DOI":"10.1038\/sj.onc.1208906"},{"key":"key\n\t\t\t\t20171011213230_B23","doi-asserted-by":"crossref","unstructured":"Sakamoto,N., Terai,T., Ajioka,Y. et al . ( 2004 ) Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors. Oncogene , 23 , 8900 \u20138907.","DOI":"10.1038\/sj.onc.1207993"},{"key":"key\n\t\t\t\t20171011213230_B24","doi-asserted-by":"crossref","unstructured":"van Engeland,M., Roemen,G.M., Brink,M., Pachen,M.M., Weijenberg,M.P., de Bruine,A.P., Arends,J.W., van den Brandt,P.A., de Goeij,A.F. and Herman,J.G. ( 2002 ) K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene , 21 , 3792 \u20133795.","DOI":"10.1038\/sj.onc.1205466"},{"key":"key\n\t\t\t\t20171011213230_B25","doi-asserted-by":"crossref","unstructured":"Li,J., Zhang,Z., Dai,Z., Popkie,A.P., Plass,C., Morrison,C., Wang,Y. and You,M. ( 2003 ) RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer. Neoplasia , 5 , 362 \u2013366.","DOI":"10.1016\/S1476-5586(03)80029-5"},{"key":"key\n\t\t\t\t20171011213230_B26","doi-asserted-by":"crossref","unstructured":"Nambiar,P.R., Nakanishi,M., Gupta,R. et al . ( 2004 ) Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer. Cancer Res. , 64 , 6394 \u20136401.","DOI":"10.1158\/0008-5472.CAN-04-0933"},{"key":"key\n\t\t\t\t20171011213230_B27","doi-asserted-by":"crossref","unstructured":"Herman,J.G., Graff,J.R., Myohanen,S., Nelkin,B.D. and Baylin,S.B. ( 1996 ) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA , 93 , 9821 \u20139826.","DOI":"10.1073\/pnas.93.18.9821"},{"key":"key\n\t\t\t\t20171011213230_B28","doi-asserted-by":"crossref","unstructured":"Jass,J.R., Whitehall,V.L., Young,J. and Leggett,B.A. ( 2002 ) Emerging concepts in colorectal neoplasia. Gastroenterology , 123 , 862 \u2013876.","DOI":"10.1053\/gast.2002.35392"},{"key":"key\n\t\t\t\t20171011213230_B29","doi-asserted-by":"crossref","unstructured":"Vogelstein,B., Fearon,E.R., Hamilton,S.R., Kern,S.E., Preisinger,A.C., Leppert,M., Nakamura,Y., White,R., Smits,A.M. and Bos,J.L. ( 1988 ) Genetic alterations during colorectal-tumor development. N. Engl. J. Med. , 319 , 525 \u2013532.","DOI":"10.1056\/NEJM198809013190901"},{"key":"key\n\t\t\t\t20171011213230_B30","doi-asserted-by":"crossref","unstructured":"Shivakumar,L., Minna,J., Sakamaki,T., Pestell,R. and White,M.A. ( 2002 ) The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell Biol. , 22 , 4309 \u20134318.","DOI":"10.1128\/MCB.22.12.4309-4318.2002"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/27\/7\/1316\/7090538\/bgi373.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T17:09:06Z","timestamp":1683392946000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/carcin\/article\/27\/7\/1316\/2391037\/Epigenetic-alterations-in-RASSF1A-in-human"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,2]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2006,3,2]]},"published-print":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgi373","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,7]]},"published":{"date-parts":[[2006,3,2]]}}}